Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
260.8 GBX | +0.77% | +4.32% | +6.80% |
May. 03 | Deutsche Bank Begins Convatec Group Coverage with Buy Rating | MT |
May. 03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- With an expected P/E ratio at 26.95 and 20.96 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 2.81 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.80% | 6.66B | B+ | ||
-3.51% | 184B | C+ | ||
-0.59% | 109B | C | ||
-2.27% | 68.37B | A | ||
+4.75% | 51.56B | B- | ||
+9.88% | 44.69B | B- | ||
+4.37% | 41.49B | B+ | ||
+3.26% | 26.75B | B | ||
+4.23% | 26.7B | A- | ||
+15.38% | 25.68B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CTEC Stock
- Ratings ConvaTec Group Plc